FDA Import Refusal 799-2700164-4/21/1 — Bgp Pharma Ulc

Bgp Pharma Ulc — FEI 3012204655

The FDA refused shipment 799-2700164-4/21/1 from Bgp Pharma Ulc (Canada) on Jan 6, 2023. The refused product falls under Drugs and Biologics — LEVOTHYROXINE SODIUM (THYROID HORMONE). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Jan 6, 2023
Country
Canada
Product Category
Drugs and Biologics
Product Code
66JCB01 LEVOTHYROXINE SODIUM (THYROID HORMONE)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.